Could a simple arm cuff protect your brain? new trial investigates
NCT ID NCT07317557
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a device that briefly restricts blood flow to the arm (remote ischemic conditioning) can improve thinking and memory in people with cerebral small vessel disease. Forty participants will receive either the real treatment or a sham version twice daily for 90 days. Researchers will measure changes in cognitive tests and brain scans to see if the treatment helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Remote ischemic conditioning using a pneumatic cuff device (IPC-906)
What this could lead to
If it works, this could point toward a non-drug treatment to slow cognitive decline in people with small vessel disease.
What could go wrong
This is a small, early-stage trial with only 40 participants. The treatment is time-intensive (twice daily for 90 days), and the sham group may also show some benefit, making it hard to prove a clear effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing Brain Hospital
Nanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••